Study: Abdominoplasty Patients Find Pain Relief with Xaracoll Implant
Among abdominoplasty patients receiving Xaracoll, a reduction in pain intensity and opioid use was observed through 24 hours post-surgery.
Among abdominoplasty patients receiving Xaracoll, a reduction in pain intensity and opioid use was observed through 24 hours post-surgery.
Set to debut in Europe, the dressing is made from biosynthetic cellulose and designed to reduce downtime and risk after procedures like microneedling and laser therapy.